Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzy Van Sanden

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Applied Bioinformatics|August 23, 2006
The use of background signal in the transformation of cDNA-microarray measurementsSuzy Van Sanden, Tomasz Burzykowski
Advances in Therapy|June 3, 2017
Comparative Efficacy of Ibrutinib Versus Obinutuzumab + Chlorambucil in First-Line Treatment of Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect ComparisonSuzy Van Sanden, Simona Baculea, Joris Diels, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 14, 2017
An Indirect Comparison of Changes in the Impact of Weight on Quality of Life Among Subjects with Type 2 Diabetes Treated with Antihyperglycemic Agents in Dual Therapy with MetforminShana B Traina, April Slee, Suzy Van Sanden, et al.
Current Medical Research and Opinion|October 13, 2015
Indirect comparison of the antiviral efficacy of peginterferon alpha 2a plus ribavirin used with or without simeprevir in genotype 4 hepatitis C virus infection, where common comparator study arms are lacking: a special application of the matching adjusted indirect comparison methodologySuzy Van Sanden, Marta Pisini, Inge Duchesne, et al.
Statistical Applications in Genetics and Molecular Biology|August 4, 2007
Using linear mixed models for normalization of cDNA microarraysPhilippe Haldermans, Ziv Shkedy, Suzy Van Sanden, et al.
Rheumatology and Therapy|June 1, 2025
A Matching-Adjusted Indirect Comparison of Guselkumab and Secukinumab in Patients with Psoriatic Arthritis Over 52 WeeksSuzy van Sanden, Agata Schubert, Barkha P Patel, et al.
The Oncologist|December 2, 2017
Comparative Efficacy of Daratumumab Monotherapy and Pomalidomide Plus Low-Dose Dexamethasone in the Treatment of Multiple Myeloma: A Matching Adjusted Indirect ComparisonSuzy Van Sanden, Tetsuro Ito, Joris Diels, et al.
Journal of Biopharmaceutical Statistics|December 30, 2011
Genomic biomarkers for a binary clinical outcome in early drug development microarray experimentsSuzy Van Sanden, Ziv Shkedy, Tomasz Burzykowski, et al.
Current Medical Research and Opinion|January 22, 2020
Efficacy of ustekinumab vs. advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysisMargaux Welty, Laura Mesana, Amie Padhiar, et al.
Journal of Health Economics and Outcomes Research|September 13, 2024
Matching-Adjusted Indirect Comparison of the Efficacy and Safety of Erdafitinib vs Enfortumab Vedotin in Patients with Locally Advanced Metastatic Urothelial CarcinomaSuzy Van Sanden, Ayman Youssef, Simona Baculea, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Applied Bioinformatics|August 23, 2006
The use of background signal in the transformation of cDNA-microarray measurementsSuzy Van Sanden, Tomasz Burzykowski
Advances in Therapy|June 3, 2017
Comparative Efficacy of Ibrutinib Versus Obinutuzumab + Chlorambucil in First-Line Treatment of Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect ComparisonSuzy Van Sanden, Simona Baculea, Joris Diels, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 14, 2017
An Indirect Comparison of Changes in the Impact of Weight on Quality of Life Among Subjects with Type 2 Diabetes Treated with Antihyperglycemic Agents in Dual Therapy with MetforminShana B Traina, April Slee, Suzy Van Sanden, et al.
Current Medical Research and Opinion|October 13, 2015
Indirect comparison of the antiviral efficacy of peginterferon alpha 2a plus ribavirin used with or without simeprevir in genotype 4 hepatitis C virus infection, where common comparator study arms are lacking: a special application of the matching adjusted indirect comparison methodologySuzy Van Sanden, Marta Pisini, Inge Duchesne, et al.
Statistical Applications in Genetics and Molecular Biology|August 4, 2007
Using linear mixed models for normalization of cDNA microarraysPhilippe Haldermans, Ziv Shkedy, Suzy Van Sanden, et al.
Rheumatology and Therapy|June 1, 2025
A Matching-Adjusted Indirect Comparison of Guselkumab and Secukinumab in Patients with Psoriatic Arthritis Over 52 WeeksSuzy van Sanden, Agata Schubert, Barkha P Patel, et al.
The Oncologist|December 2, 2017
Comparative Efficacy of Daratumumab Monotherapy and Pomalidomide Plus Low-Dose Dexamethasone in the Treatment of Multiple Myeloma: A Matching Adjusted Indirect ComparisonSuzy Van Sanden, Tetsuro Ito, Joris Diels, et al.
Journal of Biopharmaceutical Statistics|December 30, 2011
Genomic biomarkers for a binary clinical outcome in early drug development microarray experimentsSuzy Van Sanden, Ziv Shkedy, Tomasz Burzykowski, et al.
Current Medical Research and Opinion|January 22, 2020
Efficacy of ustekinumab vs. advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysisMargaux Welty, Laura Mesana, Amie Padhiar, et al.
Journal of Health Economics and Outcomes Research|September 13, 2024
Matching-Adjusted Indirect Comparison of the Efficacy and Safety of Erdafitinib vs Enfortumab Vedotin in Patients with Locally Advanced Metastatic Urothelial CarcinomaSuzy Van Sanden, Ayman Youssef, Simona Baculea, et al.
Pageof 5